Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53
H. A. Segeren, E. A. van Liere, F. M. Riemers, A. de Bruin, B. Westendorp
This study shows that oncogenic RAS increases sensitivity to ATR/CHK1 inhibitors by suppressing P53 transcriptional responses to replication stress.
bioRxiv · Jun 14, 2021Cancer Biology